Journal editors impasse with outcome reporting bias

European Journal of Clinical Investigation

Volumn 45, Issue 9, 2015, Pages 895-898

  Dal Ré, Rafael ^a   Caplan, Arthur L ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); EDITOR; HUMAN; INFORMATION PROCESSING; JOURNAL EDITOR; MEDICAL LITERATURE; OUTCOME REPORTING BIAS; PRIORITY JOURNAL; QUALITY CONTROL; ACCESS TO INFORMATION; INFORMATION DISSEMINATION; OPEN ACCESS PUBLISHING; PUBLICATION; PUBLISHING;

ACCESS TO INFORMATION; EDITORIAL POLICIES; HUMANS; INFORMATION DISSEMINATION; OPEN ACCESS PUBLISHING; PERIODICALS AS TOPIC; PUBLICATION BIAS;

EID: 84939569666     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12484     Document Type: Article

References (35)

1. International Committee of Medical Journal Editors. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. Dec 2014. Available at: www.icmje.org/icmje-recommendations.pdf. Accessed on 3 July 2015.
2. World Health Organization. International clinical trials registry platform (ICTRP). Available at: www.who.int/ictrp/en/. Accessed on 3 July 2015.
3. Food and Drug Administration Amendments Act of 2007. Public Law 110-85 www.gpo.gov/fdsys/pkg/PLAW-110publ85/pdf/PLAW-110publ85.pdf. Accessed on 3 July 2015.
4. European Commission. Directive 2001/20/EC of the European parliament and of the council of 4 April 2001 on the approximation of the laws, regulations, and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. May 2001. Available at: http://ec.europa.eu/health/files/eudralex/vol-1/dir_2001_20/dir_2001_20_en.pdf. Accessed on 3 July 2015.
5. European Medicines Agency. Posting of clinical trial summary results in European Clinical Trials Database (EudraCT) to become mandatory for sponsors as of 21 July 2014. Available at: www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/06/news_detail_002127.jsp&mid=WC0b01ac058004d5c1. Accessed on 3 July 2015.
6. Chan AW, Upshur R, Singh JA, Ghersi D, Chapuis F, Altman DG. Research protocols: waiving confidentiality for the greater good. BMJ 2006;332:1086-9.
7. Hrynaszkiewicz I, Altman DG. Towards agreement on best practice for publishing raw clinical trial data. Trials 2009;10:17.
8. Ebrahim S, Sohani ZN, Montoya L, Agarwal A, Thorlund K, Mills EJ et al. Reanalyses of randomized clinical trial data. JAMA 2014;312:1024-32.
9. Rathi VK, Strait KM, Gross CP, Hrynaszkiewicz I, Joffe S, Krumholz HM et al. Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional survey. Trials 2014;15:384.
10. Wellcome Trust. Public Health Research Data Forum. Available at: http://www.wellcome.ac.uk/About-us/Policy/Spotlight-issues/Data-sharing/Public-health-and-epidemiology/WTDV030689.htm. Accessed on 3 July 2015.
11. Clinical Study Data Request.com https://www.clinicalstudydatarequest.com/. Accessed on 3 July 2015.
12. European Medicines Agency. European Medicines Agency policy on publication of clinical data for medicinal products for human use. 2 October 2014. EMA/240810/2013. Policy/0070. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2014/10/WC500174796.pdf. Accessed on 3 July 2015.
13. PLOS Data policy summary. Available at: http://blogs.lshtm.ac.uk/rdmss/files/2014/03/PLOS-Data-Policy-Summary.pdf. Accessed on 3 July 2015.
14. Godlee F, Groves T. The new BMJ policy on sharing data from drug and device trials. BMJ 2012;345:e7888.
15. Dwan K, Gamble C, Williamson PR, Kirkham JJ, for the Reporting Bias Group. Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review. PLoS ONE 2013;8:e66844.
16. Page MJ, McKenzie JE, Kirkham J et al. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions. Cochrane Database Syst Rev 2014;10:MR000035.
17. Dwan K, Altman DG, Cresswell L et al. Comparison of protocols and registry entries to published reports for randomised controlled trials. Cochrane Database Syst Rev 2011;1:MR000031.
18. Dal-Ré R. Improving transparency of clinical trials. Trends Pharmacol Sci 2015;36:323-5.
19. Ioannidis JPA. Clinical trials: what a waste (editorial). BMJ 2014;349:g7089.
20. Chan AW, Song F, Vickers A, Jefferson T, Dickersin K, Gøtzsche PC et al. Increasing value and reducing waste: addressing inaccessible research. Lancet 2014;383:257-66.
21. Naci H, Ioannidis JP. How good is 'evidence' from clinical studies of drug effects and why might such evidence fail in the prediction of the clinical utility of drugs? Annu Rev Pharmacol Toxicol 2015;55:169-89.
22. Becker JE, Krumholz HM, Ben-Josef G, Ross JS. Reporting of results in ClinicalTrials.gov and high-impact journals. JAMA 2014;311:1063-5.
23. COPE. Committee on publication ethics. Code of conduct and best practice guidelines for journal editors. March 2011. Available at: http://publicationethics.org/resources/code-conduct. Accessed on 3 July 2015.
24. WAME Publication Ethics Committee. Recommendations on publication ethics policies for medical journals. World Association of Medical Editors. Available at: http://www.wame.org/about/recommendations-on-publication-ethics-policie. Accessed on 3 July 2015.
25. Altman DG, Moher D. Declaration of transparency for each research article. BMJ 2013;347:f4796.
26. Dal-Re R, Caplan A. Time to ensure that clinical trial appropriate results are actually published. Eur J Clin Pharmacol 2014;70:491-3.
27. Mathieu S, Chan A-W, Ravaud P. Use of trial register information during the peer review process. PLoS ONE 2013;8:e59910.
28. Viergever RF, Karam G, Reis A et al. The quality of registration of clinical trials: still a problem. PLoS ONE 2014;9:e84727.
29. Huser V, Cimino JJ. Evaluating adherence to the International Committee of Medical Journal Editors' policy of mandatory, timely clinical trial registration. J Am Med Inform Assoc 2013;20(e1):e169-74.
30. Evans S. When and how can endpoints be changed after initiation of a randomized clinical trial? PLoS Clin Trials 2007;2:e18.
31. Institute of Medicine. Sharing of Clinical Trial Data: Maximizing benefits, minimizing risk. 14 January 2015. Available at: https://www.iom.edu/Reports/2015/Sharing-Clinical-Trial-Data.aspx. Accessed on 3 July 2015.
32. Zarin DA, Tse T, Sheehan J. The proposed rule for US clinical trial registration and results submission. N Engl J Med 2015;372:174-80.
33. Dal-Re R, Ioannidis JPA, Bracken MB. A call to improve the transparency of trials of non-regulated interventions. BMJ 2015;350:h1323.
34. World Health Organization. WHO Statement on Public Disclosure of Clinical Trial Results. Available at: http://www.who.int/ictrp/results/reporting/en/. Accessed on 3 July 2015.
35. Watson R. European ombudsman questions European Medicines Agency over Abbvie redactions. BMJ 2014;349:g6904.